Mercado de inyección de dolor en las articulaciones: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00003536
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 162
Buy Now

[Informe de investigación] Se espera que el mercado de inyecciones para el dolor articular alcance los 6.996,88 millones de dólares en 2028, desde los 3.667,45 millones de dólares de 2020; Se estima que crecerá a una tasa compuesta anual del 8,5% durante 2021-2028.

Las inyecciones para el dolor articular proporcionan un alivio más rápido del dolor intenso y reducen la inflamación de las articulaciones. Varios tipos de inyecciones disponibles en el mercado incluyen inyecciones de corticosteroides, inyecciones de ácido hialurónico (HA), inyecciones de plasma rico en plaquetas (PRP) e inyecciones de matriz de tejido placentario (PTM). El crecimiento del mercado de inyecciones para el dolor articular se atribuye a factores como la alta prevalencia de trastornos musculoesqueléticos y el creciente número de lesiones deportivas. Sin embargo, los altos costos de las terapias de reparación de articulaciones obstaculizan el crecimiento del mercado.

regiones lucrativas para el mercado de inyecciones para el dolor en las articulaciones


Perspectivas del mercado


Alta prevalencia de trastornos musculoesqueléticos

Los trastornos musculoesqueléticos son afecciones médicas que afectan los músculos, los huesos y las articulaciones del cuello y los hombros. , muñecas, espalda, caderas, piernas, rodillas y pies. Estas enfermedades incluyen tendinitis, síndrome del túnel carpiano, osteoartritis, artritis reumatoide (AR), fibromialgia y fracturas óseas. Según la hoja informativa de la Organización Mundial de la Salud (OMS) actualizada en 2018, las afecciones musculoesqueléticas son el segundo mayor factor de discapacidad en todo el mundo. Según el mismo, se espera que la prevalencia y el impacto de los trastornos musculoesqueléticos aumenten con el aumento del envejecimiento de la población y el aumento de la prevalencia de los factores de riesgo de enfermedades no transmisibles (ENT) en todo el mundo. Según la Academia Estadounidense de Cirujanos Ortopédicos de 2016, Según datos de la reunión anual, ~1 de cada 2 adultos sufre un trastorno musculoesquelético en los EE. UU. Además, según los Centros para el Control y la Prevención de Enfermedades (CDC), la artritis causa un dolor intenso que afecta a millones de personas en los EE. UU. cada año. Alrededor de uno de cada cuatro pacientes con artritis, es decir, ~15 millones de un total de ~54 millones de pacientes, experimenta dolor articular grave relacionado con la artritis.

Además, la osteoartritis (OA) es una de las Los trastornos articulares más comunes en los EE. UU., causados por la rotura del cartílago articular entre los huesos. También se la conoce como enfermedad degenerativa de las articulaciones o "desgaste por uso". artritis. Según los Centros para el Control y la Prevención de Enfermedades (CDC), más de 32,5 millones de adultos en EE. UU. padecen osteoartritis. Del mismo modo, según el Servicio Nacional de Salud (NHS), más de 10 millones de personas en el Reino Unido padecen artritis u otras afecciones similares que afectan a las articulaciones. Según el seguro médico Bupa, la osteoartritis es la forma más común de artritis que prevalece en el Reino Unido; afecta a alrededor de un tercio de las personas de 45 años o más en el país, es decir, ~8,75 millones de personas. Por lo tanto, una prevalencia tan alta de trastornos musculoesqueléticos en diferentes países está aumentando el número de procedimientos de tratamiento que se llevan a cabo para los mismos, impulsando así el crecimiento del mercado de inyecciones para el dolor articular.

Información basada en fármacos

El mercado de las inyecciones para el dolor articular, por fármaco, se segmenta en ácido hialurónico, corticosteroides y otros. El segmento de corticosteroides tuvo la mayor participación de mercado en 2020 y, además, se prevé que registre la CAGR más alta durante el período de pronóstico.

Mercado de inyección para el dolor articular, por Droga: 2020 y 2028


Perspectivas basadas en el tipo de articulación

Según el tipo de articulación, el mercado de inyecciones para el dolor articular se segmenta en rodilla, pie y tobillo, hombro y codo, caderas y otras aplicaciones. El segmento de rodilla tuvo la mayor cuota de mercado en 2020 y se prevé que registre la CAGR más alta del mercado durante el período de pronóstico.

Información basada en el canal de distribución

Según el canal de distribución, el mercado de inyecciones para el dolor articular se segmenta en farmacias minoristas, farmacias hospitalarias y otros. El segmento de cuidado de heridas tuvo la mayor participación de mercado en 2020 y se estima que el segmento de injertos óseos registrará la CAGR más alta del mercado durante el período de pronóstico.

Perspectivas estratégicas

Los lanzamientos y aprobaciones de productos son las estrategias comúnmente adoptadas por las empresas para expandir su presencia global y sus carteras de productos. Además, los actores del mercado de las inyecciones para el dolor articular se centran en la estrategia de colaboración para ampliar su clientela, lo que, a su vez, les permite mantener su marca a nivel mundial.

Dolor en las articulaciones Mercado de inyección: por medicamento

  • Ácido hialurónico
  • Corticosteroide
  • Otros

Mercado de inyecciones para el dolor articular: por Tipo de Articulación

  • Rodilla
  • Pie y Tobillo
  • Hombro y Codo
  • Cadera
  • Otras

Mercado de inyecciones para el dolor articular: por canal de distribución

  • Farmacias minoristas
  • Farmacias hospitalarias
  • Otros

Mercado de inyecciones para el dolor articular: por Geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de Oriente Medio y África
  • Sur y Centroamérica (SCAM)
    • Brasil
    • Argentina
    • Resto de Sudamérica y Centroamérica
< p> 

Perfiles de la empresa

  • Chugai Pharmaceutical Co., Ltd.            
  • Bioventus Inc.       
  • Fidia Pharma USA Inc.      
  • Flexion Therapeutics, Inc.           
  • CORPORACIÓN SEIKAGAKU         
  • Ferring BV           
  • Sanofi         
  • Anika Therapeutics, Inc.             
  • Teva Pharmaceutical        
  • OrthogenRx, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are joint pain injections?

Joint pain injections are medicinal fluids inserted in the patient’s body to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the market which are corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections and placental tissue matrix (PTM) injections.

What are the driving factors for the joint pain injection market across the globe?

The global joint pain injection market growth is mainly attributed to factors such the high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, the high costs of joint repair therapies hinder the market growth.

Who are the major players in the joint pain injection market?

The joint pain injection market majorly consists of the players such as Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx among others.

The List of Companies - Joint Pain Injection Market

  1. Chugai Pharmaceutical Co., Ltd.              
  2. Bioventus Inc.                
  3. Fidia Pharma USA Inc.                
  4. Flexion Therapeutics, Inc.          
  5. SEIKAGAKU CORPORATION       
  6. Ferring B.V.     
  7. Sanofi              
  8. Anika Therapeutics, Inc.             
  9. Teva Pharmaceutical                  
  10. OrthogenRx, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports